Africa Corporate Wellness Market, by End User, 2018-2027
North America & Europe Immuno-Therapy Market By Respiratory Allergies
By Respiratory Allergies, the market is segmented into Allergic Asthma, Allergic Rhinitis, Rhino conjunctivitis, and Seasonal and Perennial Allergies
| Label | Allergic Asthma | Allergic Rhinitis | Rhino conjunctivitis | Seasonal and Perennial Allergies |
|---|---|---|---|---|
| 2019 | 291.8911 USD Million | 1005.1322 USD Million | 597.2405 USD Million | 325.9327 USD Million |
| 2020 | 278.0812 USD Million | 921.7513 USD Million | 545.5786 USD Million | 305.9106 USD Million |
| 2021 | 393.7747 USD Million | 1305.5402 USD Million | 795.2684 USD Million | 461.3538 USD Million |
| 2022 | 480.2281 USD Million | 1571.547 USD Million | 972.8355 USD Million | 582.184 USD Million |
| 2023 | 605.56 USD Million | 1944.3181 USD Million | 1216.9853 USD Million | 750.1424 USD Million |
| 2024 | 729.8691 USD Million | 2276.056 USD Million | 1430.3973 USD Million | 905.9868 USD Million |
| 2025 | 844.8788 USD Million | 2555.1933 USD Million | 1610.1842 USD Million | 1046.5638 USD Million |
| 2026 | 966.2206 USD Million | 2837.8937 USD Million | 1794.5105 USD Million | 1196.2203 USD Million |
| 2027 | 1099.1072 USD Million | 3135.7166 USD Million | 1990.4167 USD Million | 1359.9841 USD Million |
| 2028 | 1234.1407 USD Million | 3425.0921 USD Million | 2184.6559 USD Million | 1529.6478 USD Million |
| 2029 | 1369.6347 USD Million | 3699.0109 USD Million | 2371.7709 USD Million | 1701.0855 USD Million |
| 2030 | 1506.586 USD Million | 3963.6152 USD Million | 2556.2084 USD Million | 1877.6693 USD Million |
| 2031 | 1651.5274 USD Million | 4233.1355 USD Million | 2746.6513 USD Million | 2065.6285 USD Million |
| 2032 | 1801.3948 USD Million | 4499.4079 USD Million | 2938.1035 USD Million | 2261.5417 USD Million |
| 2033 | 1953.545 USD Million | 4755.8629 USD Million | 3126.7504 USD Million | 2462.568 USD Million |
| 2034 | 2112.5612 USD Million | 5012.7698 USD Million | 3318.4634 USD Million | 2673.0847 USD Million |
| 2035 | 2278.9122 USD Million | 5272.689 USD Million | 3514.616 USD Million | 2895.3468 USD Million |
| 2036 | 2453.3654 USD Million | 5535.2283 USD Million | 3715.8302 USD Million | 3129.7426 USD Million |
Data Source: Wantstats Repository
Growth Outlook
- The Therapy Market By Respiratory Allergies portion of the North America & Europe Immuno market is on a steady long-term growth path. Segment value stands at roughly USD 6795 Million in 2026 and is projected to reach USD 14834 Million by 2036 — a gain of about 118% over the forecast period, translating to a CAGR in the high single digits.
- What the regional split looks like (2026): Allergic Rhinitis leads, holding roughly 42% of segment value — the single largest regional share. Rhino conjunctivitis is the second-largest contributor. Seasonal and Perennial Allergies and Allergic Asthma make up the remainder, in descending order.
- By 2036, Allergic Rhinitis alone is expected to reach USD 5535 Million, with Rhino conjunctivitis at USD 3716 Million.
Market Dynamics
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Related Charts
View AllCountries with the most plastic surgeons worldwide
Africa Corporate Wellness Market, by Category, 2018-2027
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



